Smallpox and botulism re-designated as Group IV legal epidemics

Published: 2002-05-23 06:58:00

Updated: 2002-05-23 06:58:00

The Ministry of Health and Welfare has recently announced that the number of legal epidemics belonging to Group IV, which will be subjected to the immediate establishment of anti-epidemic measures, is increased from 55 to 57, since smallpox and botulism are re-designated based on the promulgation...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK